Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Vaccinations

Vaccinations

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Effectiveness of the Approved Nirmatrelvir/Ritonavir and Molnupiravir Regimens for Treatment of Mild/Moderate Laboratory-Confirmed SARS-CoV-2 Infection in Patients Aged 18-64 Years in Hong Kong: A Population-Based Cohort Study.

Clinical drug investigation·2026

Same author

SARS-CoV-2 vaccination and attenuation of breakthrough infection severity: A systematic global review and meta-analysis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Same author

Strain-specific differences in the response to egg-derived versus recombinant protein influenza vaccines.

Journal of virology·2026

Same author

Seroprevalence of COVID-19 among healthcare workers in Hong Kong during the first 2 years of the COVID-19 pandemic (2020-2021): a longitudinal cohort study.

BMJ open·2026

Same author

Epidemiological Trends of COVID-19 Infection and Symptom Incidence in China Following the Adjustment of Zero-COVID Policy: A Prospective, Community-Based Cohort Study.

Transboundary and emerging diseases·2026

Same author

Birth imprinting effects on the antibody responses of H7N9 patients from 2013-2018 in China.

Communications medicine·2026

Same journal

NET-inducing ability of Cutibacterium acnes clinical isolates is associated with pathogenicity in acne vulgaris.

The Journal of infectious diseases·2026

Same journal

Optimizing the Use of Proviral DNA HIV Drug Resistance Testing: Clinical Applications and Cautions.

The Journal of infectious diseases·2026

Same journal

Monitoring HLA-A2-restricted T cell responses and BCLA-specific serostatus during human latent Toxoplasma gondii infection suggests the implication of CD8+ T cells in parasite containment.

The Journal of infectious diseases·2026

Same journal

Cryptosporidiosis in Ptients with Inborn Errors of Immunity: Retrospective cohort study of the French National Reference Center (CEREDIH).

The Journal of infectious diseases·2026

Same journal

Type 3 fimbrial regulation underpins anti-MrkA immunotherapeutic efficacy in experimental Klebsiella pneumoniae infection.

The Journal of infectious diseases·2026

Same journal

Rationalising heterogeneity in Staphylococcus aureus bacteraemia: current progress and future goals.

The Journal of infectious diseases·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 10, 2025

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

Improved Methods for Vaccine Effectiveness Studies.

George N Okoli¹, Benjamin J Cowling^1,2

¹WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, The University of Hong Kong, Hong Kong Special Administrative Region of China.

The Journal of Infectious Diseases

|October 15, 2024

Summary

This summary is machine-generated.

Evaluating vaccine effectiveness (VE) is vital for public health. Recent findings emphasize addressing correlated vaccination behaviors, using negative controls, and accounting for prior infections to improve VE study accuracy and reliability.

Keywords:

evaluation methods test-negative design vaccine effectiveness

More Related Videos

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

Related Experiment Videos

Last Updated: Jun 10, 2025

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

Area of Science:

Epidemiology
Public Health
Biostatistics

Background:

Evaluating public health investments in vaccination programs is crucial for efficiency and effectiveness.
Vaccine effectiveness (VE) studies, particularly the test-negative design (TND), are vital for confirming vaccine impact and guiding improvements.
The TND offers simplicity and cost-efficiency but can be compromised by inconsistent symptom definitions and retrospective data.

Purpose of the Study:

To summarize recent findings for refining VE estimation methods.
To highlight the importance of addressing specific biases in VE studies.
To improve the accuracy and reliability of vaccine effectiveness data.

Main Methods:

Summarizing recent research findings on VE estimation.
Identifying key factors that influence VE study validity.
Recommending methodological adjustments for epidemiological studies.

Main Results:

Correlated vaccination behaviors need to be addressed when estimating VE.
Negative control variables can effectively reduce confounding in VE studies.
Accounting for prior infection history is recommended to enhance VE study accuracy.

Conclusions:

Refined VE estimation methods are essential for accurate public health assessments.
Addressing methodological limitations in VE studies ensures reliable data for policy decisions.
Improved VE study designs contribute to more effective vaccination program strategies.